Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase I/IIa study of SYNB-1618 in healthy volunteers establishes dose for patients with PKU

Sep. 4, 2018

BenevolentAI Bio discloses orexin receptor antagonists

Sep. 4, 2018

Immutep advances development of LAG-3 agonist antibody IMP-761

Sep. 4, 2018

Janssen Pharmaceutica NV synthesizes 5-HT2B receptor antagonists

Sep. 4, 2018

I-Mab Biopharma presents anti-CD73 antibodies for cancer

Sep. 4, 2018

TACI found to have prognostic value in heart failure

Sep. 4, 2018

MedImmune patents new fusion proteins for heart failure

Sep. 4, 2018

Kodiak completes enrollment in phase I study of KSI-301 in diabetic macular edema

Sep. 4, 2018

XPO5 gene polymorphism found to protect from coronary artery disease risk

Sep. 4, 2018

In rare encephalitis, neurons contribute to their own demise

Sep. 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...